# Hangzhou Juzheng Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-juzheng-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Latest round: Series A (Jan 24, 2025)
- Investors on record: 4

## About

Based in Hangzhou, China, and founded in 2021, Hangzhou Juzheng Medical Technology operates as a medical device company that focuses on the production and sales of vascular interventional treatment devices. It was recognized as the National High-tech Enterprise. The team members have experience in medicine, machinery, materials, and other fields, and R&D personnel account for over half of the total. In September 2023, it reached strategic cooperation with Neurovita. In June 2024, the company's intracranial balloon dilatation catheter was approved by the NMPA certificate. In January 2025, Hangzhou Juzheng Medical Technology closed a series A funding. In October 2025, Hangzhou Juzheng Medical Technology raised a venture funding from returning investor TigerYeah Capital.

The company mainly develops and produces innovative medical devices in the field of vascular intervention. Products include coronary vascular remodeling catheters, intracranial laser balloon dilatation catheters, occlusion hemostat series, etc. The products can be used to treat cardiovascular and cerebrovascular diseases.

The company generates revenue by providing vascular interventional treatment devices.

The company will use the series A funding to support the clinical validation of the company's core products such as coronary vascular remodeling catheters.

## Funding rounds

- Series A, Jan 24, 2025 — Lotus Lake Capital, Anji Industrial Fund
- Angel, Jun 13, 2022 — TigerYeah Capital, YSCapital

## Investors

- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel
- YSCapital (https://capitalatlas.ai/funds/yscapital) — Angel
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Anji Industrial Fund — Series A